0
  • Notifications
  • No notifications yet

  • View All Notifications
ChemDmart
Chemxpert Database
  • About
    • About
    • Leadership
    • Advisory Board
  • Products
    • ChemProtel - Product Intelligence
    • CompFolio - One Company Profile
    • CompGroupe - Group Company Profile
    • ChemScape - Data Landscape
    • ChemDmart - E-Market Place
    • DataIntel - Data Analytics/Trends
    • DataFeed - Data News/Feed
    • CompShow- Company Showcase
  • Sources
  • Subscription
  • User Guide
  • Contact
  • Book Demo Log In
  1. Home
  2. All News
  3. Eqt To Acquire Leading Healthcare Technology Solutions Provider Gebbs Healthcare Solutions
News Feed
course image
  • 11 Sep 2024
  • Admin
  • News Article

EQT to Acquire Leading Healthcare Technology Solutions Provider, GeBBS Healthcare Solutions

Overview

EQT announced that the BPEA Private Equity Fund VIII (EQT Private Capital Asia) has agreed to acquire a controlling beneficial interest in GeBBS, a global provider of healthcare outsourcing solutions, from ChrysCapital.

GeBBS Enhances US Healthcare RCM with Comprehensive Solutions

  • GeBBS offers a range of services which help US-based healthcare providers improve their financial performance by optimizing revenue cycle management (RCM) processes and ensuring accurate coding and billing practices. 
  • The fragmented global RCM services market continues to witness double-digit growth, driven by long-term trends such as growing patient volumes, increasing complexity within US healthcare operations, and limited availability of skilled resources for critical functions. 
  • GeBBS is well-positioned to capitalize on these tailwinds on the back of its strong solutions suite, which spans the front, middle and back-end of the RCM value chain. 
  • The company – which was founded in 2005 and has established a global footprint of 13,000 employees spread across the US, India, Dominican Republic and Philippines – benefits from strong relationships with a diverse range of customers across US-based hospitals, physician groups, and other healthcare firms.

EQT Private Capital Asia

EQT Private Capital Asia will support the Company’s next phase of accelerated growth and innovation, drawing on EQT’s deep experience in the healthcare technology segment, global network of industry experts and dedicated digital value-creation team.
Statement from EQT Private Capital India

  • Hari Gopalakrishnan, partner in the EQT Private Capital Asia advisory team and Head of EQT Private Capital India, said: “Healthcare technology is a key investment theme for EQT. GeBBS has developed a robust business with a clear focus on supporting healthcare providers through industry leading solutions.” 
  • “We see strong alignment between GeBBS’ growth ambitions and EQT’s experience in creating long-term value. We look forward to supporting the team through EQT’s proven value creation playbook to further accelerate GeBBS’ growth momentum.”

Words from CEO & MD: GeBBS

  • "We are excited to welcome an investor of EQT's stature, whose profound expertise in healthcare and technology services promises to be a game-changer as we embark on the next thrilling chapter of GeBBS", said Dr. Milind Godbole, CEO and managing director of GeBBS. 
  • "EQT has an impressive track record of building and scaling technology and business services platforms successfully. With a strong foundation built under ChrysCapital’s ownership, we believe we are well positioned to take GeBBS to the next level under EQT’s ownership using its well proven value creation playbook."

From the MD: ChrysCapital Advisors

  • Akshat Babbar, managing director, ChrysCapital Advisors, said,""We are extremely glad to have partnered with GeBBS Healthcare. The Company’s deep capabilities and technological prowess make it the partner of choice for large health systems in the US.” 
  • “Since our investment, the company has delivered industry-leading organic growth and, through four key acquisitions, added new competencies and expanded its global footprint. We wish EQT all the best as they continue the journey and take GeBBS to new heights."

EQT Private Capital Asia was advised by Ropes & Gray, JSA Law, Deloitte Touche Tohmatsu Limited, and PricewaterhouseCooper. The selling shareholders were advised by Jefferies and Avendus.

With this transaction, BPEA Private Equity Fund VIII is expected to be 70-75 percent invested (including closed and/or signed investments, announced public offers, if applicable, and less any expected syndication). The transaction is expected to close in Q4 2024.

EQT Organization

  • EQT is a purpose-driven global investment organization with EUR 246 billion in total assets under management (EUR 133 billion in fee-generating assets under management), within two business segments – Private Capital and Real Assets. 
  • EQT owns portfolio companies and assets in Europe, Asia-Pacific and the Americas and supports them in achieving sustainable growth, operational excellence and market leadership.

GeBBS Healthcare Solutions

  • GeBBS Healthcare Solutions is a global provider of healthcare outsourcing solutions, specializing in revenue cycle management, health information management, and medical billing services. 
  • The company offers a range of services designed to help healthcare providers, including hospitals, physician practices, and insurance companies, improve their financial performance by optimizing revenue cycle processes and ensuring accurate coding and billing practices.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!

Categories

image
Product Related Updates
image
Certificates/Accreditation
image
Approval/Launch
image
Clinical Trial Update
image
Licensing/Partnering/Collaboration Deal
image
ODD/BTA/FTA Status
image
Merger/Acquisition
image
Warning/Recalls

Lifescience Intellipedia Pvt. Ltd.

C-89, Sector-65 Noida-U.P. 201301 (India)
Toll-Free: 18004190155
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com

USEFUL LINKS

  • Home
  • Privacy Policy
  • Terms & Conditions
  • Terms Of Use
  • Refund Policy
  • Blogs

OUR PRODUCTS

  • ChemProtel - Product Intelligence
  • CompFolio - One Company Profile
  • CompGroupe - Group Company Profile
  • ChemScape - Data Landscape
  • ChemDmart - E-Market Place
  • DataIntel - Data Analytics/Trends
  • DataFeed - Data News/Feed
  • CompShow- Company Showcase

LOCATION

© Copyright Lifescience Intellipedia Pvt. Ltd.. All Rights Reserved

Fill The Form